CARD for Community Pharmacy Vaccinations - Phase 2
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Toronto
About this trial
This study is phase 2 of a cluster trial integrating the CARD (Comfort Ask Relax System) in community pharmacies affiliated with Wholehealth Pharmacy Partners. It involves continuing CARD in pharmacies randomized to CARD in phase 1 of the trial (2023-2024 fall/winter vaccination season), and initiating CARD in pharmacies randomized to Control (usual care) in phase 1 of the trial. Both groups will use CARD for delivery of vaccinations during the 2024-2025 fall/winter vaccination season.
Eligibility criteria
Qualifiers
clients undergoing vaccination in participating pharmacies and providers working in participating pharmacies
Disqualifiers
able to speak and write in English
Trial design
Treatments tested in this trial
- Sustained CARD
- First-time CARD
Treatment groups
500 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Toronto
Lead sponsor
Wholehealth Pharmacy Partners
Collaborator
Source ClinicalTrials.gov